 |
|
Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen
Clin Mol Hepatol. 2016;22(3):327-335. Published online 2016 Sep 25 DOI: https://doi.org/10.3350/cmh.2016.0049
|
|
Citations to this article as recorded by
 The association of metabolic dysfunction-associated steatotic liver disease (MASLD) with the risk of myocardial infarction: a systematic review and meta-analysis
Qiong Lv, Huashan Zhao
Annals of Medicine.2024;[Epub] CrossRef Cost‐effectiveness study of FIB‐4 followed by transient elastography screening strategy for advanced hepatic fibrosis in a NAFLD at‐risk population
Huiyul Park, Eileen L. Yoon, Mimi Kim, Sun‐Hong Kwon, Donghee Kim, Ramsey Cheung, Hye‐Lin Kim, Dae Won Jun
Liver International.2024; 44(4): 944. CrossRef Heating Induced Nanoparticle Migration and Enhanced Delivery in Tumor Treatment Using Nanotechnology
Qimei Gu, Liang Zhu
Bioengineering.2024; 11(9): 900. CrossRef Hepatocyte Kctd17 Inhibition Ameliorates Glucose Intolerance and Hepatic Steatosis Caused by Obesity-induced Chrebp Stabilization
Ah-Reum Oh, Yelin Jeong, Junjie Yu, Dao Thi Minh Tam, Jin Ku Kang, Young Hoon Jung, Seung-Soon Im, Sang Bae Lee, Dongryeol Ryu, Utpal B. Pajvani, KyeongJin Kim
Gastroenterology.2023; 164(3): 439. CrossRef Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators
Balamurugan Ramatchandirin, Alexia Pearah, Ling He
Life.2023; 13(2): 515. CrossRef Hepatic Clstn3 Ameliorates Lipid Metabolism Disorders in High Fat Diet-Induced NAFLD through Activation of FXR
Jingyi Guo, Shangyi Huang, Qincheng Yi, Naihua Liu, Tianqi Cui, Siwei Duan, Jiabing Chen, Jiayu Li, Jun Li, Lei Wang, Yong Gao, Guangning Nie
ACS Omega.2023; 8(29): 26158. CrossRef MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón
Frontiers in Medicine.2022;[Epub] CrossRef Protective Effect and Mechanism of Plant-Based Monoterpenoids in Non-alcoholic Fatty Liver Diseases
Wenji Zhang, Hui Lin, Wenli Cheng, Zhenrui Huang, Wenjuan Zhang
Journal of Agricultural and Food Chemistry.2022; 70(16): 4839. CrossRef Liposomal Form of 2,4-Dinitrophenol Lipophilic Derivatives as a Promising Therapeutic Agent for ATP Synthesis Inhibition
Kseniya Yu. Vlasova, Petr Ostroverkhov, Daria Vedenyapina, Tamara Yakimova, Alla Trusova, Galina Yurievna Lomakina, Stepan Sergeevich Vodopyanov, Mikhail Grin, Natalia Klyachko, Vladimir Chekhonin, Maxim Abakumov
Nanomaterials.2022; 12(13): 2162. CrossRef Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population
Huiyul Park, Eileen L. Yoon, Mimi Kim, Jonghyun Lee, Seon Cho, Dae Won Jun, Eun-Hee Nah
Frontiers in Medicine.2022;[Epub] CrossRef Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
Tian-Yi Ren, Xiao-Yan Li, Jian-Gao Fan
Clinical and Molecular Hepatology.2021; 27(1): 83. CrossRef Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
Jae Seung Lee, Dong Hyun Sinn, Soo Young Park, Hye Jung Shin, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Joo Hyun Oh, Jung Il Lee, Seung Up Kim
Cancers.2021; 13(18): 4567. CrossRef Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease
Ho Soo Chun, Mi Na Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Journal of Cachexia, Sarcopenia and Muscle.2021; 12(5): 1168. CrossRef Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease
Mi Na Kim, Kyungdo Han, Juhwan Yoo, Yeonjung Ha, Young Eun Chon, Ju Ho Lee, Tracey G. Simon, Andrew T. Chan, Seong Gyu Hwang
Scientific Reports.2021;[Epub] CrossRef BTT‐105 ameliorates hepatic fibrosis in non‐alcoholic fatty liver animal model
Hye Young Kim, Sang Bong Ahn, Jeong‐Min Hong, Ju Hee Oh, Waqar Khalid Saeed, Gyu Sik Kim, Hyun Kim, Jong Koo Kang, Sukmo Kang, Dae Won Jun
The FASEB Journal.2021;[Epub] CrossRef Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease
Dong Hyun Sinn, Danbee Kang, Soo Jin Cho, Seung Woon Paik, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
European Journal of Gastroenterology & Hepatology.2021; 33(1S): e529. CrossRef Alcoholic and Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development
Komal Thapa, Ajmer Singh Grewal, Neha Kanojia, Lata Rani, Neelam Sharma, Sukhbir Singh
Current Drug Discovery Technologies.2021; 18(3): 333. CrossRef Non‐alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study
Dong Hyun Sinn, Danbee Kang, Yoosoo Chang, Seungho Ryu, Soo Jin Cho, Seung Woon Paik, Young Bin Song, Roberto Pastor‐Barriuso, Eliseo Guallar, Juhee Cho, Geum‐Youn Gwak
Journal of Gastroenterology and Hepatology.2020; 35(5): 833. CrossRef Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
Jeong-Ju Yoo, Yang Jae Yoo, Woo Ram Moon, Seung Up Kim, Soung Won Jeong, Ha Na Park, Min Gyu Park, Jae Young Jang, Su Yeon Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Sang Gyune Kim, Young Seok Kim, Ji Hoon Kim, Jong
The Korean Journal of Internal Medicine.2020; 35(6): 1346. CrossRef Non-invasive monitoring of hepatic steatosis via acoustic structure quantification of ultrasonography with MR spectroscopy as the reference standard
Dong Ho Lee, Jae Young Lee, Min Sun Park, Joon Koo Han
Ultrasonography.2020; 39(1): 70. CrossRef Weight Change and Development of Subclinical Carotid Atherosclerosis Among Metabolically Healthy Adults: A Cohort Study
Dong Hyun Sinn, Danbee Kang, Soo Jin Cho, Yoosoo Chang, Seungho Ryu, Young Bin Song, Seung Woon Paik, Yun Soo Hong, Di Zhao, Eliseo Guallar, Juhee Cho, Geum-Youn Gwak
The Journal of Clinical Endocrinology & Metabolism.2020; 105(3): e410. CrossRef Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk
Eugene Han, Yong-ho Lee, Young Dae Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Kwang-Hyub Han, Hyo Suk Nam, Ji Hoe Heo, Seung Up Kim
American Journal of Gastroenterology.2020; 115(4): 584. CrossRef Does limited expression of toll-like receptor 9 actually contribute to T cell activation and liver damage in nonalcoholic steatohepatitis?
Hyuk Soo Eun
Clinical and Molecular Hepatology.2020; 26(2): 236. CrossRef Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Man-Hoon Han, Jee Hyun Lee, Gyeonghwa Kim, Eunhye Lee, Yu Rim Lee, Se Young Jang, Hye Won Lee, Jae Min Chun, Young Seok Han, Jun Sik Yoon, Min Kyu Kang, Won Kee Lee, Young Oh Kweon, Won Young Tak, Soo Young Park, Jung Gil Park, Keun Hur
Genes.2020; 11(5): 545. CrossRef Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis
Jung Gil Park, Gyeonghwa Kim, Se Young Jang, Yu Rim Lee, Eunhye Lee, Hye Won Lee, Man-Hoon Han, Jae Min Chun, Young Seok Han, Jun Sik Yoon, Min Kyu Kang, Young Oh Kweon, Won Young Tak, Soo Young Park, Keun Hur
Life.2020; 10(10): 230. CrossRef Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease
Min Kyu Kang, Kyeong Ok Kim, Min Cheol Kim, Jung Gil Park, Byung Ik Jang
Digestive Diseases.2020; 38(6): 507. CrossRef Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease
Min Cheol Kim, Jung Gil Park, Byung Ik Jang, Heon Ju Lee, Won Kee Lee
Medicine.2019; 98(6): e14139. CrossRef Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology
In Cheol Yoon, Jong Ryeol Eun
Yeungnam University Journal of Medicine.2019; 36(2): 67. CrossRef The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease
Young-Kyu Kim, Oh-Sung Kwon, Kyu Hee Her
Medicine.2019; 98(27): e16018. CrossRef How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
Jung Hwan Yu, Jin-Woo Lee
Clinical and Molecular Hepatology.2019; 25(3): 280. CrossRef Underlying nonalcoholic fatty liver disease is a significant factor for breast cancer recurrence after curative surgery
Young-Sun Lee, Ha Seok Lee, Sung Won Chang, Chan Uk Lee, Jung Sun Kim, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Chang Hee Lee, Sang Uk Woo, Jae Hong Seo, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun
Medicine.2019; 98(39): e17277. CrossRef
ASPECTS OF IMMUNOLOGICAL STATUS AND CARBON METABOLISM IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN CORRELATION WITH ITS FIBROUS TRANSFORMATION
Y. M. Stepanov, V. I. Didenko, I. S. Konenko, O. M. Tatarchuk, O. P. Petishko
Bulletin of Problems Biology and Medicine.2019; 3(152): 196. CrossRef Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease
Do Seon Song, U Im Chang, Sung-Goo Kang, Sang-Wook Song, Jin Mo Yang
Gut and Liver.2019; 13(6): 658. CrossRef Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010–2015
Yunkoo Kang, Sowon Park, Seung Kim, Hong Koh
BMC Pediatrics.2018;[Epub] CrossRef Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD)
Zahra Dehnavi, Farkhonde Razmpour, Mahmoud Belghaisi Naseri, Mohsen Nematy, Seyed Ali Alamdaran, Hassan Ali Vatanparast, Mohsen Azimi Nezhad, Bita Abbasi, Azita Ganji
Hepatitis Monthly.2018;[Epub] CrossRef CGplus, a standardized herbal composition ameliorates non-alcoholic steatohepatitis in a tunicamycin-induced mouse model
Myong-Min Lee, Hyeong-Geug Kim, Sung-Bae Lee, Jin-Seok Lee, Won-Yong Kim, Seung-Hoon Choi, Sam-Keun Lee, Chang-Kyu Byun, Pung-Mi Hyun, Chang-Gue Son
Phytomedicine.2018; 41: 24. CrossRef Neue und bewährte Therapieansätze bei NASH
Peter C. Konturek
MMW - Fortschritte der Medizin.2018; 160(5): 50. CrossRef Estimated Prevalence of Adolescents with Nonalcoholic Fatty Liver Disease in Korea
Yunkoo Kang, Sowon Park, Seung Kim, Hong Koh
Journal of Korean Medical Science.2018;[Epub] CrossRef Recent advances in understanding and managing non-alcoholic fatty liver disease
Somaya Albhaisi, Arun Sanyal
F1000Research.2018; 7: 720. CrossRef Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
Stephen A. Harrison, Manal F. Abdelmalek, Stephen Caldwell, Mitchell L. Shiffman, Anna Mae Diehl, Reem Ghalib, Eric J. Lawitz, Don C. Rockey, Raul Aguilar Schall, Catherine Jia, Bryan J. McColgan, John G. McHutchison, G. Mani Subramanian, Robert P. Myers,
Gastroenterology.2018; 155(4): 1140. CrossRef Serological biomarkers associate ultrasound characteristics of steatohepatitis in mice with liver cancer
Guozhen Cui, Robert C Martin, Xingkai Liu, Qianqian Zheng, Harshul Pandit, Ping Zhang, Wei Li, Yan Li
Nutrition & Metabolism.2018;[Epub] CrossRef Serotonin signals through a gut-liver axis to regulate hepatic steatosis
Wonsuk Choi, Jun Namkung, Inseon Hwang, Hyeongseok Kim, Ajin Lim, Hye Jung Park, Hye Won Lee, Kwang-Hyub Han, Seongyeol Park, Ji-Seon Jeong, Geul Bang, Young Hwan Kim, Vijay K. Yadav, Gerard Karsenty, Young Seok Ju, Chan Choi, Jae Myoung Suh, Jun Yong Par
Nature Communications.2018;[Epub] CrossRef Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease
Waqar Khalid Saeed, Dae Won Jun, Kiseok Jang, Sang Bong Ahn, Ju Hee Oh, Yeon Ji Chae, Jai Sun Lee, Hyeon Tae Kang
World Journal of Gastroenterology.2018; 24(48): 5477. CrossRef Changes in the Structure of the Liver during Obesity (Literature Review)
V. I. Prymachenko
Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2018; 4(2): 45. CrossRef Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage
Alessia Di Costanzo, Laura D'Erasmo, Licia Polimeni, Francesco Baratta, Paola Coletta, Michele Di Martino, Lorenzo Loffredo, Ludovica Perri, Fabrizio Ceci, Anna Montali, Gabriella Girelli, Bruna De Masi, Antonio Angeloni, Carlo Catalano, Marianna Maranghi
Atherosclerosis.2017; 257: 232. CrossRef Salvia-Nelumbinis Naturalis Formula Improved Inflammation in LPS Stressed Macrophages via Upregulating MicroRNA-152
Zansong Ma, Xiangbing Shu, Jie Huang, Haiyan Zhang, Zhen Xiao, Li Zhang
Mediators of Inflammation.2017; 2017: 1. CrossRef Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos
Metabolism.2017; 71: 182. CrossRef Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease
Hye Won Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang Joon Kim, Kwang-Hyub Han
Digestive Diseases and Sciences.2017; 62(8): 2150. CrossRef Non-alcoholic Fatty Liver Disease: A Clinical Update
Joseph M Pappachan, Shithu Babu, Babu Krishnan, Nishal C Ravindran
Journal of Clinical and Translational Hepatology.2017; XX(XX): XX. CrossRef A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis
Baek Gyu Jun, Won Young Park, Eui Ju Park, Jae Young Jang, Soung Won Jeong, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, So Young Jin, Suyeon Park, Seung Up Kim
PLOS ONE.2017; 12(8): e0182784. CrossRef The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter
Hye Won Lee, Kwang Joon Kim, Kyu Sik Jung, Young Eun Chon, Ji Hye Huh, Kyeong Hye Park, Jae Bock Chung, Chang Oh Kim, Kwang-Hyub Han, Jun Yong Park, Han-Chieh Lin
PLOS ONE.2017; 12(10): e0187066. CrossRef Serum fetuin A level is associated with nonalcoholic fatty liver disease in Chinese population
Zhengsen Cui, Rong Xuan, Yunmei Yang
Oncotarget.2017; 8(63): 107149. CrossRef
|